Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden
Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden
复制标题
DOI:
10.5853/jos.2017.02565
复制
发表时间:
2018-05-01
影响因子:
8.2
通讯作者:
Peters, Nils
中科院分区:
文献类型:
--
作者:
Duering, Marco;Konieczny, Marek J.;Peters, Nils
Background and Purpose Neurofilament light chain (NfL) is a blood marker for neuroaxonal damage. We assessed the association between serum NfL and cerebral small vessel disease (SVD), which is highly prevalent in elderly individuals and a major cause of stroke and vascular cognitive impairmentMethods Using a cross-sectional design, we studied 53 and 439 patients with genetically defined SVD (Cerebral Autosomal-Dominant Arteriopathy with Subcortica I Infarcts and Leukoencephalopathy [CADASIL]) and sporadic SVD, respectively, as well as 93 healthy controls. Serum NfL was measured by an ultrasensitive single-molecule array assay. We quantified magnetic resonance imaging (MRI) markers of SVD, i.e., white matter hyperintensity volume, lacune volume, brain volume, microbleed count, and mean diffusivity obtained from diffusion tensor imaging. Clinical characterization included neuropsychological testing in both SVD samples. CADASIL patients were further characterized for focal neurological deficits (National Institutes of Health stroke scale [NIHSS]) and disability (modified Rankin scale [mRS]).Results Serum NfL levels were elevated in both SVD samples (P